pharmaceutical product development for pruritus  pain  cara therapeutics careers  working to fundamentally change the way pain and pruritus are managed developing proprietary firstinclass compounds to treat pain inflammation and pruritus without inducing many of the side effects associated with current therapies learn more acute pain acute pain is of sudden onset and is usually the result of a clearly defined cause such as injury chronic pain chronic pain persists for two weeks or months and is usually associated with an underlying condition pruritus pruritus or itch is defined as an unpleasant sensation of the skin that provokes the urge to scratch press releases cara therapeutics to announce second quarter  financial results on august    cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease  cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee  cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients  cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment  events  presentations q  cara therapeutics earnings conference call  cr oa phase b data conference call  ckdassociated pruritus kol meeting  q  cara therapeutics earnings conference call  cara ceo interviewed on cnbcs mad money  investor relations  cara therapeutics careers  news  investors investor relations shareholder search  overview press releases events  presentations corporate governance management board of directors committee composition contact the board financials  filings sec filings stock information historic stock lookup analyst coverage investor faqs contact us cara therapeutics is a clinicalstage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors we are developing a novel and proprietary class of product candidates that target the bodys peripheral nervous system and have demonstrated efficacy in patients with moderatetosevere pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics our most advanced product candidate intravenous or iv cr has demonstrated significant pain relief and a favorable safety and tolerability profile in three phase  clinical trials in patients with acute postoperative pain we are also developing iv cr in uremic pruritus and as well as an oral version of cr or oral cr for acute and chronic pain   press releases jul   cara therapeutics to announce second quarter  financial results on august   jul   cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease view all events  presentations aug   at  pm et q  cara therapeutics earnings conference call view all briefcase printed docs email alerts downloads snapshot print page rss news feeds share facebook google linkedin twitter email rss clinical drug development  biotechnology company  cara therapeutics careers  about company overview cara therapeutics is a clinicalstage biotechnology company located in stamford ct focused on developing and commercializing new chemical entities designed to fundamentally change the way acute pain chronic pain and pruritus are managed  we aim to achieve this by developing new products that selectively target the body’s peripheral kappa opioid receptors cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderatetosevere pain and pruritus itch without inducing many of the undesirable side effects typically associated with currently available pain and itch therapeutics contact us investors overview cara’s most advanced compound cr is currently undergoing clinical testing for acute pain chronic pain and uremic pruritus itch in multiple randomized doubleblind placebocontrolled phase  trials in patients undergoing laparoscopic hysterectomy or bunionectomy procedures iv cr treatment resulted in statistically significant reductions in both pain intensity and opioidrelated side effects with well over  subjects dosed to date cr was found to be well tolerated without incurring the dysphoric and psychotomimetic side effects that have been reported with centrally acting cnsactive kappa opioid receptor agonists learn more about working at cara therapeutics careers learn more about kappa opioid receptor agonists koras and cr learn more clinical drug development pipeline  cara therapeutics careers  pipeline  technology our pipeline cara therapeutics drug development drug indication preclinical phase i phase ii phase iii commercialization pain pain iv cr postop pain oral cr chronic pain oral cr chronic pain pruritus pruritus iv cr pruritus ckdhd oral cr pruritus non opioid analgesics for pain  pruritus management  cara theraputics careers  therapeutic focus fundamentally different approach to pain  itch pain management a need for innovation medicines for acute and chronic pain management have not fundamentally changed for over  years  mu opioids eg morphine oxycodone hydrocodone nsaids eg aspirin ibuprofen and acetaminophen account for over  of the drugs taken for pain management the first mu opioid morphine was discovered in  the first nsaid aspirin was launched in  subsequent nsaids like indomethacin and ibuprofen were discovered in the s and launched in the s acetaminophen was launched in the s there has been modest improvements in these drug classes over the years since the first products launched however the drugs taken today still fundamentally work in the same manner and have similar side effects and problems as the drugs that were discovered and launched  to  years ago it is time for a fundamental change in the way we manage pain working to fundamentally change pain management cara therapeutics is looking to fundamentally change pain management  instead of focusing our efforts on modestly improving old compounds cara is developing a completely new class of medicine called kappa opioid receptor agonists koras  koras target a completely different receptor in the body the kappa opioid receptor to treat pain in a fundamentally new way our lead pipeline product cr is a peripherally acting koras to date cr has shown in phase  clinical trials promising pain relief without many of the traditional side effects that you see mu opioids morphine oxycodone and hydrocodone and nsaids ibuprofen   cr pain management pruritus itch management a major unmet need similar to the treatments for pain management there has been very little innovation in medicines that specifically treat patients’ pruritus or itch the mainstays for treating itch today are still corticosteroids and antihistamines the first corticosteroids and antihistamines like diphenhydramine or benadryl were discovered and launched in the s there have been modest improvements in these drug classes in the subsequent years but the products utilized today are very similar in action and side effects as those used over  years ago cr pruritus en v working to fundamentally change pruritus itch management cara therapeutics is also looking to fundamentally change pruritus itch management  cara is developing a completely new class of medicine called kappa opioid receptor agonists koras  koras target a completely different receptor in the body the kappa opioid receptor to treat itch in a fundamentally new way  our lead pipeline product cr is a peripherally acting koras  to date cr has shown in phase  clinical trials promising improvements in itch relief in a very difficult to treat itch condition called uremic pruritus an itch that develops in chronic kidney disease ckd and in particular dialysis patients learn more about kappa opioid receptor agonists koras and cr learn more terms of use  cara therapeutics careers  cara therapeutics inc terms of use please read the agreement carefully this agreement governs your use of wwwcaratherapeuticscom “website” this website is owned by cara therapeutics inc you must read and accept the terms and conditions of this agreement and the privacy policy by accessing the website you are entering into a legally binding contract and you agree to be bound by these terms of use while using the website if you do not agree to these terms and conditions do not access view or otherwise use this website this agreement may be modified by cara therapeutics inc from time to time without prior notice and you agree to be bound by such modifications or revisions such modifications are effective upon posting on our official website all materials distributed in the website the “materials” are either owned by or licensed to cara therapeutics inc cara therapeutics inc and its licensors retain all proprietary rights to the materials all materials are protected by worldwide copyright laws except for downloading one copy of the materials on any single computer for your personal noncommercial home use you must not reproduce prepare derivative works based upon distribute perform or display the materials without first obtaining the written permission of cara therapeutics inc materials must not be used in any unauthorized manner cara therapeutics inc will use reasonable efforts to include uptodate and accurate information on this website but make no representations warranties or assurances as to the accuracy currency or completeness of the material cara therapeutics inc website shall not be liable for any damages or injury resulting from your access to or inability to access this website or from your reliance on any information provided at this website this website is for residents of the united states  this terms of use and your use of the website shall be governed by the laws of new york and you hereby agree to the exclusive jurisdiction of the courts of new york for resolution of any disputes arising from or related in any way to your use of the website this terms of use andor the materials contained herein if any provision of this terms of use is held to be unenforceable such provision shall be severed and the remaining provisions enforced this website may provide links or references to other sites any such links are provided for your convenience and do not constitute an endorsement of that site nor of any product service or other material offered on that site by cara therapeutics inc if you click on the link you will be leaving this website and will be subject to different terms and conditions of use and privacy policy we encourage you to read all privacy policies and terms and conditions of use the trademarks service marks trade names trade dress and products in this internet website are protected in the united states and internationally no use of any of these may be made without the prior written authorization of the owners of this website except to identify the products or services of cara therapeutics inc any personally identifiable information in electronic communications to this internet website is governed by this website’s privacy policy  by transmitting any message physical or electronic communication you are granting cara therapeutics inc a perpetual royaltyfree nonexclusive and irrevocable right and license to reproduce prepare derivative works based upon distribute perform or display such message in whole or in part in any form media or technology known or hereafter developed and cara therapeutics shall be free to use or copy any such information including any ideas inventions concepts techniques or knowhow disclosed therein for any purposes such purposes may include disclosure to third parties andor developing manufacturing andor marketing goods or services the sender of any communications to this website or otherwise to the owners of this website shall be responsible for the content and information contained therein including its truthfulness and accuracy cara therapeutics inc c  all rights reserved contact information  cara therapeutics careers  contact cara therapeutics inc  stamford plaza  elm street th floor stamford ct      we’d love to hear from you if you have any questions or comments please fill out the brief form below and one of our friendly representatives will be in touch name first last email organizationim interested inplease select oneinvestor informationproductpipeline informationmediageneral inquirycomments clinical drug development pipeline  cara therapeutics careers  pipeline  technology our pipeline cara therapeutics drug development drug indication preclinical phase i phase ii phase iii commercialization pain pain iv cr postop pain oral cr chronic pain oral cr chronic pain pruritus pruritus iv cr pruritus ckdhd oral cr pruritus cara therapeutics inc nasdaqcara cara therapeutics inc cara product news news  stocknewscom     follow us stocktwits twitter cara therapeutics inc cara product news news cara – announces topline results from a phase b trial of an oral tablet formulation of cr in patients with osteoarthritis of the knee or hip statistically significant  percent reduction in mean joint pain score in hip patients at eight weeks with  mg dose jun    pm  by stocknewscom staff product news key facts surrounding this news item cara had a powr rating of a strong buy coming into today cara was  above its day moving average coming into today cara was  above its day moving average coming into today cara was  above its day moving average coming into today cara was  above its day moving average coming into today cara was  above its day moving average coming into today cara had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about cara therapeutics inc cara cara therapeutics is a clinicalstage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors the company was founded in  and is based in shelton connecticut view our full cara ticker page with ratings news and more cara at a glance cara current powr rating™ overall powr rating™ cara current price   more cara ratings data and news cara price reaction the day of this event jun  cara closing price cara volume from avgleading up to this eventcara mo returnnaafter this eventcara day returncara day returncara day return cara price chart more cara therapeutics inc cara news view all eventdate symbol news detail start price end price change powr rating loading please wait view all cara news page generated in  seconds cara therapeutics inc cara medical equipment deals and alliances profile report updated  prices from usd  — bioportfoliocom bioportfolio biotech healthcare and medical resources advertisement topics all topics biotechnology biotech business biotech products cancer cardiovascular dermatology drug discovery endocrinology gastroenterology immunology infectious diseases mental health neurology obstetrics orthopedics public health respiratory rheumatology urology  track topics on twitter track topics that are important to you printed from bioportfoliocom cara therapeutics inc cara medical equipment deals and alliances profile report updated  prices from usd   edt  jul   bioportfolio report blog summarycara therapeutics inc cara therapeutics is a clinicalstage biotechnology company that develops novel therapeutics for pain and inflammation and pruritus the company products include kappa receptor agonists and cannabinoid receptors it offers products for therapeutic areas which include acute pain chronic pain neuropathic pain and pruritus cara therapeutics develops analgesics g proteincoupled receptors which are class of membrane proteins using its dimer screen technology the company develops molecules at novel analgesic and antiinflammatory targets using proprietary drug screening technology it serves pharmaceutical and healthcare sectors cara therapeutics is headquartered in stamford connecticut the uscara therapeutics inc cara medical equipment deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings the report provides detailed information on mergers and acquisitions equitydebt offerings private equity venture financing and partnership transactions recorded by the company over a five year period the report offers detailed comparative data on the number of deals and their value categorized into deal types subsector and regionsglobaldata derived the data presented in this report from proprietary inhouse medical etrack deals database and primary and secondary researchscope financial deals analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year chart and table displaying information encompassing the number of deals and value reported by the company by year for a five year period deals by type chart and table depicting information including the number of deals and value reported by the company by type such as mergers and acquisitions equitydebt offering etc deals by region chart and table presenting information on the number of deals and value reported by the company by region which includes north america europe asia pacific the middle east and africa and south and central america deals by subsector chart and table showing information on the number of deals and value reported by the company by subsector major deals information on the companys major financial deals each such deal has a brief summary deal type deal rationale and deal financials and target companys major public companies key financial metrics and ratios business description a brief description of the companys operations key employees a list of the key executives of the company important locations and subsidiaries a list and contact details of key centers of operation and subsidiaries of the company key competitors a list of the key competitors of the company key recent developments a brief on recent news about the companyreasons to buyget detailed information on the companys financial deals that enable you to understand the companys expansiondivestiture and fund requirements the profile enables you to analyze the companys financial deals by region by year by business segments and by type for a five year periodunderstand the companys business segments expansion  divestiture strategy the profile presents deals from the companys core business segments perspective to help you understand its corporate strategyaccess elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company detailed information on major recent deals includes a summary of each deal deal type deal rationale deal financials and target companys key financial metrics and ratiosequip yourself with detailed information about the companys operations to identify potential customers and suppliers the profile analyzes the companys business structure locations and subsidiaries key executives and key competitorsstay uptodate on the major developments affecting the company recent developments concerning the company presented in the profile help you track important eventsgain key insights into the company for academic or business research key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needsnote some sections may be missing if data is unavailable for the company related biotechnology pharmaceutical and healthcare news caras uremic pruritus drug wins fda breakthrough status cara therapeutics cara updates on crclin oa phase b data  slideshow cara therapeutics cara ceo derek chalmers on q  results  earnings call transcript cara therapeutics cara ceo derek chalmers on q  results  earnings call transcript cara therapeutics cara presents at th annual needham healthcare conference  slideshow original article cara therapeutics inc cara medical equipment deals and alliances profile report updated  prices from usd  next article more from bioportfolio on cara therapeutics inc cara medical equipment deals and alliances profile report updated  prices from usd  related companies related events related clinical trials related pubmed entries related medications quick linksadvanced search  login  subscribe  rss quick search advertisement   relevant topics biotechnology  biotech using living things to create products or to do tasks for humans about biotechnology  biotech biotechnology is the practice of using plants animals and microorganisms such as bacteria as well as biological processes  such as the ripen anesthesiology an anesthesiologist us english or anaesthetist british english is a physician trained in anesthesia and perioperative medicine anesthesiologists are physicians who provide medical care to patients in a wide variety of usually acute situations  pain disorder pain is a feeling sharp or dull triggered in the nervous system which can be transient or constant pain can be specific to one area of the body eg back abdomen or chest or more general all over the body eg muscles ache from the flu without pain  news quicklinks search biotech medical and healthcare news popular biotech medical and healthcare news biotech news by article type biotech news by location bioportfolio bloggers publishing your news on bioportfolio recent visitor news searches bioportfolio limited about us contact us social media twitter  accounts twitter google linkedin publish content publish publish your press release advertise agreements agreements medical disclaimer privacy tools mybioportfolio rss help faqs sitemaps xml sitemap this site complies with the honcode standard for trustworthy health information verify here the information provided by bioportfoliocom is not a substitute for professional medical advice diagnosis or treatment the bioportfolio site is sponsored bioportfolio limited with offices at stafford house  prince of wales road dorchester dt pw england if you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “fair use” and legitimately infringes on your or your clients copyright we may be contacted concerning copyright matters at prioritybioportfoliocom all rights reserved all other trademarks recognized copyright   bioportfolio limited site developed by alacrify ltd taking a look under the hood at cara therapeutics inc cara shares contact us economy culturearts it scitech sports world media health care usa cara profile  cara therapeutics inc stock  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow  cara therapeutics inc caranasdaqgm  nasdaqgm delayed price currency in usdadd to watchlist at close pm edt  after hours pm edtpeople also watchinsyzynegwphtwmjfacbffsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystscara therapeutics inc stamford plazath floorstamford ct united stateshttpwwwcaratherapeuticscomsector healthcareindustry biotechnologyfull time employees key executivesnametitlepayexercisedagedr derek t chalmers phd dsccofounder chief exec officer pres and directorknadr joseph stauffer do mbachief medical officerknadr frederique menzaghi phdvp of rdknadr michael e lewis phdcofounder and chief scientific advisornanamr josef schoellchief financial officer and treasurernanaamounts are as of december   and compensation values are for the last fiscal year ending on that date pay is salary bonuses etc exercised is the value of options exercised during the fiscal year currency in usddescriptioncara therapeutics inc a clinicalstage biopharmaceutical company focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the united states it is developing product candidates that target the bodys peripheral nervous system the companys lead product candidate comprises iv cr which is in phase iii clinical trials for the treatment of patients with acute postoperative pain in adult patients as well as in phase iiiii clinical trial for the treatment of uremic pruritus disease it is also developing oral cr that is in phase iib clinical trial to treat moderatetosevere acute and chronic pain as well as in phase i clinical trial to treat uremic pruritus and cr which is in preclinical trial for the treatment of neuropathic and inflammatory pain the company has license agreements with maruishi pharmaceutical co ltd to develop manufacture and commercialize drug products containing cr for acute pain and uremic pruritus in japan and chong kun dang pharmaceutical corporation to develop manufacture and commercialize drug products containing cr in south korea cara therapeutics inc was founded in  and is headquartered in stamford connecticutcorporate governancecara therapeutics inc’s iss governance qualityscore as of july   is  the pillar scores are audit  board  shareholder rights  compensation corporate governance scores courtesy of institutional shareholder services iss scores indicate decile rank relative to index or region a decile score of  indicates lower governance risk while a  indicates higher governance riskyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated page not found  market research reports® inc skip to main content home faqs contact us become publisher blog  items  search form search this site search you are here home global markets direct cara therapeutics inc product pipeline review  page not found × error message the page you requested does not exist for your convenience a search was performed using the query global markets direct cara therapeutics inc product pipeline review  enter terms search your search for  gave back  results pruritus  pipeline review h  pruritus  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide pruritus – catalog  diseases global markets direct global march  price  pruritus  pipeline review h  pruritus  pipeline review h  summary global markets direct’s ‘pruritus  pipeline review h ’ provides an overview of the pruritus catalog  diseases global markets direct global august  price  pruritus  pipeline review h  pruritus  pipeline review h  summary global markets direct’s ‘pruritus  pipeline review h ’ provides an overview of the pruritus catalog  diseases global markets direct global march  price  hyperalgesia  pipeline review h  hyperalgesia  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide hyperalgesia catalog  diseases global markets direct global february  price  pruritus  pipeline review h  pruritus  pipeline review h  summary global markets direct’s ‘pruritus  pipeline review h ’ provides an overview of the pruritus’s catalog  diseases global markets direct global november  price  osteoarthritis pain  pipeline review h  osteoarthritis pain  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide catalog  diseases global markets direct global may  price  postoperative pain  pipeline review h  postoperative pain  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide post catalog  diseases global markets direct global february  price  hyperalgesia  pipeline review h  hyperalgesia  pipeline review h  summary global markets direct’s ‘hyperalgesia  pipeline review h ’ provides an overview of the catalog  diseases global markets direct global july  price  hyperalgesia  pipeline review h  hyperalgesia  pipeline review h  summary global markets direct’s ‘hyperalgesia  pipeline review h ’ provides an overview of the catalog  diseases global markets direct global february  price  hyperalgesia  pipeline review h  hyperalgesia  pipeline review h  summary global markets direct’s ‘hyperalgesia  pipeline review h ’ provides an overview of the catalog  diseases global markets direct global january  price  osteoarthritis pain  pipeline review h  osteoarthritis pain  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide catalog  diseases global markets direct global october  price  hyperalgesia  pipeline review h  hyperalgesia  pipeline review h  summary global markets direct’s ‘hyperalgesia  pipeline review h ’ provides an overview of the catalog  diseases global markets direct global august  price  acute pain  pipeline review h  acute pain  pipeline review h  summary global markets direct’s ‘acute pain  pipeline review h ’ provides an overview of the acute catalog  diseases global markets direct global august  price  postoperative pain  pipeline review h  postoperative pain  pipeline review h  summary global markets direct’s ‘postoperative pain  pipeline review h ’ provides an catalog  diseases global markets direct global july  price  postoperative pain  pipeline review h  postoperative pain  pipeline review h  summary global markets direct’s ‘postoperative pain  pipeline review h ’ provides an catalog  diseases global markets direct global february  price           … next filter by report date past year  apply past year filter past month  apply past month filter filter by industry chemicals  apply chemicals filter specialty chemicals  apply specialty chemicals filter country overview chemicals  apply country overview chemicals filter reagents  apply reagents filter manufacturing chemicals  apply manufacturing chemicals filter industry  manufacturing  apply industry  manufacturing filter machinery  apply machinery filter country overview industry  manufacturing  apply country overview industry  manufacturing filter manufacturers  apply manufacturers filter construction  apply construction filter company reports industry  manufacturing  apply company reports industry  manufacturing filter metals  apply metals filter agriculture  apply agriculture filter aerospace  apply aerospace filter pharma  healthcare  apply pharma  healthcare filter healthcare  apply healthcare filter country overview pharma  healthcare  apply country overview pharma  healthcare filter medical devices  apply medical devices filter biotechnology  apply biotechnology filter company reports pharma  healthcare  apply company reports pharma  healthcare filter diagnostics  apply diagnostics filter deals  alliances pharma  healthcare  apply deals  alliances pharma  healthcare filter computing  electronics  apply computing  electronics filter electrical products  apply electrical products filter electrical components  apply electrical components filter country overview computing  electronics  apply country overview computing  electronics filter it services  apply it services filter consumer  retail  apply consumer  retail filter consumer services  apply consumer services filter country overview consumer  retail  apply country overview consumer  retail filter house  home  apply house  home filter cosmetics  personal care  apply cosmetics  personal care filter food  beverages  apply food  beverages filter food  apply food filter country overview food  beverages  apply country overview food  beverages filter automotive  apply automotive filter components  apply components filter country overview automotive  apply country overview automotive filter banking  finance  apply banking  finance filter investments  apply investments filter securities brokers  traders  apply securities brokers  traders filter capital markets  apply capital markets filter country overview banking  finance  apply country overview banking  finance filter strategy banking  finance  apply strategy banking  finance filter insurance  apply insurance filter energy  utilities  apply energy  utilities filter company reports energy  utilities  apply company reports energy  utilities filter utilities  apply utilities filter country overview energy  utilities  apply country overview energy  utilities filter business  government  apply business  government filter filter by country global  apply global filter asia pacific  apply asia pacific filter china  apply china filter japan  apply japan filter india  apply india filter australia  apply australia filter malaysia  apply malaysia filter south korea  apply south korea filter vietnam  apply vietnam filter philippines  apply philippines filter indonesia  apply indonesia filter thailand  apply thailand filter singapore  apply singapore filter north america  apply north america filter usa  apply usa filter canada  apply canada filter europe  apply europe filter united kingdom  apply united kingdom filter germany  apply germany filter france  apply france filter italy  apply italy filter spain  apply spain filter turkey  apply turkey filter russian federation  apply russian federation filter netherlands  apply netherlands filter sweden  apply sweden filter norway  apply norway filter switzerland  apply switzerland filter poland  apply poland filter belgium  apply belgium filter denmark  apply denmark filter finland  apply finland filter ireland  apply ireland filter austria  apply austria filter czech republic  apply czech republic filter greece  apply greece filter portugal  apply portugal filter romania  apply romania filter africa  apply africa filter south africa  apply south africa filter middle east  apply middle east filter south america  apply south america filter brazil  apply brazil filter mexico  apply mexico filter argentina  apply argentina filter asia  apply asia filter oceania  apply oceania filter central america  apply central america filter eurasia  apply eurasia filter central asia  apply central asia filter clients who trust us need tailor made market research solution we can help you with that too contact us about us at market research reports inc we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best ie take timecritical decisions we work with our associate global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs be it custom research or syndicated research reports contact us market research reports inc  coastal hwy lewes de  usa usa  india  marketresearchreports email protected user login username  password  create new account request new password log in latest blog posts investment opportunities in taiwan semiconductor chemical and consumer goods will lead the pack global investment opportunities in ports and terminals stay connected sign up to our newsletter email address  subscribe research industries home automotive banking  finance business  government chemicals computing  electronics consumer  retail energy  utilities food  beverages industry  manufacturing marketing  advertising media pharma  healthcare telecom transport travel  leisure our company about us publications by country faqs privacy policy terms  conditions  copyright  market research reports inc all rights reserved m market research reports and the m market research reports logo are registered trademarks of market research reports inc disclaimer market research reports inc has no affiliation to and is not associated with any other websites or organizations we offer syndicated research reports like country analysis swot analysis competitive intelligence industry reports company reports and market analysis  trends reports and custom market research from our website marketresearchreportscom only if you are looking for a market research solution for your research requirements please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us cara key statistics  cara therapeutics inc financial ratios  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close cara therapeutics inc nasdaq cara go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus cara therapeutics inc after hours  quotes are delayed by  min jul    pm cara quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   company description cara therapeutics inc is a clinicalstage company which engages in the research development and commercialization of pharmaceutical products its portfolio includes opioidbased products anestheticbased drugs and analgesics that targets to alleviate itch and pain the company was founded by  cara therapeutics inc is a clinicalstage company which engages in the research development and commercialization of pharmaceutical products its portfolio includes opioidbased products anestheticbased drugs and analgesics that targets to alleviate itch and pain the company was founded by derek t chalmers michael e lewis and frédérique menzaghi on july   and is headquartered in stamford ct valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr derek t chalmers   president chief executive officer  director mr josef c schoell   cfo  principal accounting officer dr joseph w stauffer   chief medical officer dr frèdèrique menzaghi   vice presidentresearch  development mr scott terrillion   secretary  general counsel insider actions – purchase – sale  – number of transactions  date name shares transaction value  derek t chalmers president  ceo director    disposition at  per share   frèdèrique menzaghi vpresearch  development    disposition at  per share   derek t chalmers president  ceo director    derivativenonderivative trans at  per share   esperante bv director    disposition at  per share   esperante bv director    disposition at  per share   frèdèrique menzaghi vpresearch  development    disposition at  per share   rho ventures    acquisition at  per share   rho ventures    acquisition at  per share   rho ventures    acquisition at  per share   rho ventures    acquisition at  per share   josef c schoell chief financial officer    derivativenonderivative trans at  per share   josef c schoell chief financial officer    derivativenonderivative trans at  per share   derek t chalmers president  ceo director    derivativenonderivative trans at  per share   frèdèrique menzaghi vpresearch  development    disposition at  per share   frèdèrique menzaghi vpresearch  development    disposition at  per share   michael e lewis chief scientific advisor    disposition at  per share   derek t chalmers president  ceo director    disposition at  per share  newslatestcompanyuscara marketwatch news on cara update cara therapeutics shares surge  premarket on positive trial results  am july    ciara linnane cara therapeutics reports positive results in earlystage trial of pain treatment in kidney disease  am july    ciara linnane cara therapeutics shares jump  in premarket trade  am july    ciara linnane nasdaq sp  close higher as tech stocks rally while dow dips  pm july    wallace witkowski cara therapeutics stock declines  in morning trade  am july    emma court cara therapeutics stock plunges after mixed trial results prompts analyst downgrade  am june    tomi kilgore harry boxer’s two biotech stocks and two tech stocks to watch  pm june    harry boxer harry boxer four stocks locked in a strong uptrend  pm may    harry boxer sp  balks at trendline resistance nasdaq stages latest false breakout  pm april    michael ashbaugh harry boxer’s five technology and biotechnology stocks to watch  pm march    harry boxer cara therapeutics shares surge  on positive results in trial of up treatment  am march    ciara linnane harry boxer watch these two biotechnology stocks  am feb    harry boxer cara therapeutics shares are up more than  premarket  am nov    marketwatch newsnonmarketwatchcompanyuscara other news on cara these  marijuana stocks all jumped at least  last week  am july    motley fool top marijuana stocks on the nasdaq  am july    investopediacom  reason why cara therapeutics ended june down   pm july    motley fool why this biotech could be poised for a run after toppling  in june  pm july    investors business daily heres why cara therapeutics inc is on the rise today  pm july    motley fool caras oral cr welltolerated in earlystage study shares ahead  premarket  am july    seeking alpha this marijuana stock has lost more than half its value in  weeks  am july    motley fool  stocks to watch on wednesday square inc sq cara therapeutics inc cara and healthcare services group inc hcsg  am july    investorplacecom can cara therapeutics stock bounce back  pm july    motley fool raytheon has a lot of upside  cramers lightning round   am july    seeking alpha brunch craft beer and investing a millennials portfolio  pm july    seeking alpha why best buy co inc bby abercrombie  fitch co anf and cara therapeutics inc cara are  of today’s worst stocks  pm july    investorplacecom heres why nobodys itching to buy cara therapeutics stock today  pm july    motley fool biotech forum daily digest  ipo activity increasing spotlight on flexion therapeutics  pm july    seeking alpha cara option alert feb   puts sweep  at the ask    vs  oi ref  pm july    benzingacom phase b cara therapeutics data provides great short opportunity  am july    seeking alpha daily insider ratings round up  mcc cnbka opk cara kfs mmac  am july    seeking alpha up in smoke heres why this marijuana stock absolutely imploded last week  am july    motley fool biotech stock roundup cara plunges on study data regulatory updates  more  am july    zackscom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july  am july    seeking alpha loading more headlines at a glance cara therapeutics inc  parrott drive shelton connecticut  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue  net income m employees  annual report for cara newspressreleasecompanyuscara press releases on cara cara therapeutics to announce second quarter  financial results on august    pm today pm july    globenewswire potential blockbuster treatment for alzheimers disease stands out among medical cannabis companies  am july    pr newswire  prf the next gold rush is green  am july    pr newswire  prf sales of legal cannabis products are expected to accelerate  am july    pr newswire  prf cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease  am july    globenewswire correction todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals inc  am july    accesswire investors covered call reports for cara therapeutics national beverage corp kraft heinz co mcdonalds and att include trade ideas that offer returns of  or more  am july    pr newswire  prf todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals  am july    accesswire cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee  pm june    globenewswire legal cannabis and cbdbased products projected to gain popularity  am june    pr newswire  prf todays research reports on trending tickers aveo pharmaceuticals and cara therapeutics  am june    accesswire todays stock options reports include trade ideas for cara therapeutics chemours co dunkin brands trade desk inc and united parcel service  am june    pr newswire  prf biotech stocks showing signs of resurgence  am june    pr newswire  prf cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients  am june    globenewswire todays research reports on stocks to watch hologic and cara therapeutics  am june    accesswire cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment  am june    globenewswire consumers spending on legal cannabis products projected to grow  am june    pr newswire  prf research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma  am june    pr newswire  prf cbd market becomes major part of the cannabis industry  am may    pr newswire  prf cannabisbased therapies with potential to dull the pain of opioid abuse  am may    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest predfin prices ipo higher than expected for  billion valuation pspacex valuation jumps to  billion on new financing round phoward marks says bitcoin isn’t real—and we can all blame millennials for its rise pheadline sen graham the skinny bill is a disaster psenate passes russia sanctions bill on  vote pscaramucci provides a shocking bannon comparison that defies anatomy pethereum struggles to rise as regulatory scrutiny weighs on digital currency pthis fund strategist says there’s at least one way companies can survive amazon’s onslaught pthis basic balanced index fund is beating the hedge fund averages ptesla earnings will model  live up to the hype pwhat a constant stream of oil company spending cuts means for crude prices pall the companies in jeff bezos’s empire in one large chart pbitcoin investors things may get very ugly soon if this chart overlay is right pbaidu adrs rally  after earnings beat pbreakingsenators demand house conference promise before voting on skinny obamacare repeal pjonathan golub leaves rbc to head equities strategy at credit suisse report pamazon earnings forecast shows spending expected to continue pa quarter of sp ’s  climb due to five stocks yes those five pnuvasive shares drop after announced coo cfo departures pboston beer jumps on stellar secondquarter earnings loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cara stock price  cara therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern p redfin prices ipo higher than expected for  billion valuation p spacex valuation jumps to  billion on new financing round p headline sen graham the skinny bill is a disaster p updated howard marks says bitcoin isn’t real—and we can all blame millennials for its rise p senate passes russia sanctions bill on  vote p updated scaramucci provides a shocking bannon comparison that defies anatomy p updated ethereum struggles to rise as regulatory scrutiny weighs on digital currency p this fund strategist says there’s at least one way companies can survive amazon’s onslaught p this basic balanced index fund is beating the hedge fund averages p tesla earnings will model  live up to the hype to be replaced home investing quotes stocks united states cara overview compare quotes stock screener earnings calendar sectors nasdaq cara us nasdaq join td ameritrade find a broker cara therapeutics inc watchlist createcaraalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones update cara therapeutics shares surge  premarket on positive trial results shares of cara therapeutics inc surged  in premarket trade wednesday after the company reported positive results in an earlystage trial of a treatment for chronic kidney diseaseassociated pruritus patients or ckdap pruritus or itch is a common symptom for patients with chronic renal failure affecting about half of those with stage  to  ckd cara said results from the phase  trial of oral cr in chronic kidney disease patients undergoing hemodialysis showed all four tablet strengths were welltolerated on a daily basis or after dialysis three times a week cr is a peripherally acting kappa opioid receptor agonist currently in development for the treatment of acute and chronic pain and pruritus said cara plasma levels of cr attained after oral administration of the  mg tablet strength were close to those attained with the  mcgkg iv cr dose which demonstrated significant clinical benefit in another recent trial the company said frédérique menzaghi phd vice president of research and development at cara said the data will inform the design of a planned oral cr pruritus clinical program in the nondialysis ckdap population which the company is planning to start later this year cara shares have gained  in  while the sp  has gained  jul   at  am et by ciara linnane cara therapeutics shares jump  in premarket trade cara therapeutics shares jump  in premarket trade jul   at  am et by ciara linnane cara therapeutics reports positive results in earlystage trial of pain treatment in kidney disease cara therapeutics reports positive results in earlystage trial of pain treatment in kidney disease jul   at  am et by ciara linnane nasdaq sp  close higher as tech stocks rally while dow dips jul   at  pm et by sara sjolin cara therapeutics stock declines  in morning trade cara therapeutics stock declines  in morning trade jul   at  am et by emma court cara therapeutics stock plunges after mixed trial results prompts analyst downgrade shares of cara therapeutics inc plunged  in premarket trade friday after mixed results from a phase b trial of the biotechnology companys pain medication prompted a downgrade at janney montgomery scott analyst ken trbovich cut his rating to neutral from buy saying the results of the trial werent strong enough to achieve statistical significance at the highest dose and did not show an effect at lower doses the result of the trial gives us less confidence in the outlook for a positive outcome for the phase  than we had previously trbovich wrote in a note to clients the stock had nearly tripled year to date through thursday while the ishares nasdaq biotechnology etf had rallied  and the sp  had gained  jun   at  am et by tomi kilgore opinion harry boxer’s two biotech stocks and two tech stocks to watch jun   at  pm et by harry boxer opinion harry boxer four stocks locked in a strong uptrend may   at  pm et by harry boxer sp  balks at trendline resistance nasdaq stages latest false breakout apr   at  pm et by michael ashbaugh opinion harry boxer’s five technology and biotechnology stocks to watch mar   at  pm et by harry boxer cara therapeutics shares surge  on positive results in trial of up treatment mar   at  am et by ciara linnane opinion harry boxer watch these two biotechnology stocks feb   at  am et by harry boxer cara therapeutics shares are up more than  premarket nov   at  am et by marketwatch stocks to watch nvidia nrg energy american airlines twitter among the companies with shares expected to trade actively in monday’s session are nvidia corp nrg energy inc american airlines group inc and twitter inc jul   at  am et on the wall street journal bear case backs down mar   at  am et on the wall street journal  small healthcare stocks poised to double dec   at  am et on barrons holy grail pain pills without the high mar   at  pm et on the wall street journal up and down the ladder the latest comings and goings at astellas johnson  johnson and… dec   at  am et on the wall street journal recent news other news press releases these  marijuana stocks all jumped at least  last week jul   at  am et on motley fool top marijuana stocks on the nasdaq most marijuana companies trade otc but these names are listed on the nasdaq and enjoy greater liquidity jul   at  am et on investopediacom  reason why cara therapeutics ended june down  jul   at  pm et on motley fool why this biotech could be poised for a run after toppling  in june cara therapeutics cara stock popped wednesday after the biotech unveiled strong data from a phase  trial of chronic kidney disease patients — giving its shares a leg up for the second day running cara shares have been volatile over the past month cara was the de facto leader of a latejune spike in the biotech market the stock rocketed  in just six trading days but lost it all on the last day of the month amid a mixed trial in hip and jul   at  pm et on investors business daily heres why cara therapeutics inc is on the rise today jul   at  pm et on motley fool caras oral cr welltolerated in earlystage study shares ahead  premarket caras oral cr welltolerated in earlystage study shares ahead  premarket jul   at  am et on seeking alpha  stocks to watch on wednesday square inc sq cara therapeutics inc cara and healthcare services group inc hcsg  stocks to watch on wednesday square inc sq cara therapeutics inc cara and healthcare services group inc hcsg jul   at  am et on investorplacecom this marijuana stock has lost more than half its value in  weeks jul   at  am et on motley fool can cara therapeutics stock bounce back jul   at  pm et on motley fool raytheon has a lot of upside  cramers lightning round  raytheon has a lot of upside  cramers lightning round  jul   at  am et on seeking alpha brunch craft beer and investing a millennials portfolio brunch craft beer and investing a millennials portfolio jul   at  pm et on seeking alpha why best buy co inc bby abercrombie  fitch co anf and cara therapeutics inc cara are  of today’s worst stocks why best buy co inc bby abercrombie  fitch co anf and cara therapeutics inc cara are  of today’s worst stocks jul   at  pm et on investorplacecom heres why nobodys itching to buy cara therapeutics stock today jul   at  pm et on motley fool biotech forum daily digest  ipo activity increasing spotlight on flexion therapeutics biotech forum daily digest  ipo activity increasing spotlight on flexion therapeutics jul   at  pm et on seeking alpha cara option alert feb   puts sweep  at the ask    vs  oi ref cara option alert feb   puts sweep  at the ask    vs  oi ref jul   at  pm et on benzingacom phase b cara therapeutics data provides great short opportunity phase b cara therapeutics data provides great short opportunity jul   at  am et on seeking alpha daily insider ratings round up  mcc cnbka opk cara kfs mmac daily insider ratings round up  mcc cnbka opk cara kfs mmac jul   at  am et on seeking alpha up in smoke heres why this marijuana stock absolutely imploded last week jul   at  am et on motley fool biotech stock roundup cara plunges on study data regulatory updates  more key highlights in the biotech sector include mixed data from cara cara and regulatory updates from companies like biomarin jul   at  am et on zackscom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july biotech forum daily digest  biotech fritters away some gains  fda calendar events in july jul   at  am et on seeking alpha cara therapeutics to announce second quarter  financial results on august   cara therapeutics to announce second quarter  financial results on august   jul   at  pm et on globenewswire potential blockbuster treatment for alzheimers disease stands out among medical cannabis companies potential blockbuster treatment for alzheimers disease stands out among medical cannabis companies jul   at  am et on pr newswire  prf the next gold rush is green the next gold rush is green jul   at  am et on pr newswire  prf sales of legal cannabis products are expected to accelerate sales of legal cannabis products are expected to accelerate jul   at  am et on pr newswire  prf cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease jul   at  am et on globenewswire correction todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals inc correction todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals inc jul   at  am et on accesswire investors covered call reports for cara therapeutics national beverage corp kraft heinz co mcdonalds and att include trade ideas that offer returns of  or more investors covered call reports for cara therapeutics national beverage corp kraft heinz co mcdonalds and att include trade ideas that offer returns of  or more jul   at  am et on pr newswire  prf todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals jul   at  am et on accesswire cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee jun   at  pm et on globenewswire legal cannabis and cbdbased products projected to gain popularity legal cannabis and cbdbased products projected to gain popularity jun   at  am et on pr newswire  prf todays research reports on trending tickers aveo pharmaceuticals and cara therapeutics todays research reports on trending tickers aveo pharmaceuticals and cara therapeutics jun   at  am et on accesswire todays stock options reports include trade ideas for cara therapeutics chemours co dunkin brands trade desk inc and united parcel service todays stock options reports include trade ideas for cara therapeutics chemours co dunkin brands trade desk inc and united parcel service jun   at  am et on pr newswire  prf biotech stocks showing signs of resurgence biotech stocks showing signs of resurgence jun   at  am et on pr newswire  prf cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients jun   at  am et on globenewswire todays research reports on stocks to watch hologic and cara therapeutics todays research reports on stocks to watch hologic and cara therapeutics jun   at  am et on accesswire cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment jun   at  am et on globenewswire consumers spending on legal cannabis products projected to grow consumers spending on legal cannabis products projected to grow jun   at  am et on pr newswire  prf research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma jun   at  am et on pr newswire  prf cbd market becomes major part of the cannabis industry cbd market becomes major part of the cannabis industry may   at  am et on pr newswire  prf cannabisbased therapies with potential to dull the pain of opioid abuse cannabisbased therapies with potential to dull the pain of opioid abuse may   at  am et on pr newswire  prf cara therapeutics inc cara therapeutics inc is a clinicalstage company which engages in the research development and commercialization of pharmaceutical products its portfolio includes opioidbased products anestheticbased drugs and analgesics that targets to alleviate itch and pain the company was founded by derek t chalmers michael e lewis and frédérique menzaghi on july   and is headquartered in stamford ct see full profile analyst ratings sell under hold over buy number of ratings  full ratings cara therapeutics topline data disappoints this is why you do phase  jun   at  am et on benzingacom benzingas top upgrades downgrades for june   jun   at  am et on benzingacom cara therapeutics ends mixed month with upgrade from vetr crowd mar   at  pm et on benzingacom competitors name chg  market cap depomed inc  m durect corp  m acorda therapeutics inc  b cumberland pharmaceuticals inc  m johnson  johnson  b competitor data provided by partner content trending tickers powered by amzn  intc  sbux  fslr  bidu  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest predfin prices ipo higher than expected for  billion valuation pspacex valuation jumps to  billion on new financing round phoward marks says bitcoin isn’t real—and we can all blame millennials for its rise pheadline sen graham the skinny bill is a disaster psenate passes russia sanctions bill on  vote pscaramucci provides a shocking bannon comparison that defies anatomy pethereum struggles to rise as regulatory scrutiny weighs on digital currency pthis fund strategist says there’s at least one way companies can survive amazon’s onslaught pthis basic balanced index fund is beating the hedge fund averages ptesla earnings will model  live up to the hype pwhat a constant stream of oil company spending cuts means for crude prices pall the companies in jeff bezos’s empire in one large chart pbitcoin investors things may get very ugly soon if this chart overlay is right pbaidu adrs rally  after earnings beat pbreakingsenators demand house conference promise before voting on skinny obamacare repeal pjonathan golub leaves rbc to head equities strategy at credit suisse report pamazon earnings forecast shows spending expected to continue pa quarter of sp ’s  climb due to five stocks yes those five pnuvasive shares drop after announced coo cfo departures pboston beer jumps on stellar secondquarter earnings loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest predfin prices ipo higher than expected for  billion valuation pspacex valuation jumps to  billion on new financing round phoward marks says bitcoin isn’t real—and we can all blame millennials for its rise pheadline sen graham the skinny bill is a disaster psenate passes russia sanctions bill on  vote pscaramucci provides a shocking bannon comparison that defies anatomy pethereum struggles to rise as regulatory scrutiny weighs on digital currency pthis fund strategist says there’s at least one way companies can survive amazon’s onslaught pthis basic balanced index fund is beating the hedge fund averages ptesla earnings will model  live up to the hype pwhat a constant stream of oil company spending cuts means for crude prices pall the companies in jeff bezos’s empire in one large chart pbitcoin investors things may get very ugly soon if this chart overlay is right pbaidu adrs rally  after earnings beat pbreakingsenators demand house conference promise before voting on skinny obamacare repeal pjonathan golub leaves rbc to head equities strategy at credit suisse report pamazon earnings forecast shows spending expected to continue pa quarter of sp ’s  climb due to five stocks yes those five pnuvasive shares drop after announced coo cfo departures pboston beer jumps on stellar secondquarter earnings loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest predfin prices ipo higher than expected for  billion valuation pspacex valuation jumps to  billion on new financing round phoward marks says bitcoin isn’t real—and we can all blame millennials for its rise pheadline sen graham the skinny bill is a disaster psenate passes russia sanctions bill on  vote pscaramucci provides a shocking bannon comparison that defies anatomy pethereum struggles to rise as regulatory scrutiny weighs on digital currency pthis fund strategist says there’s at least one way companies can survive amazon’s onslaught pthis basic balanced index fund is beating the hedge fund averages ptesla earnings will model  live up to the hype pwhat a constant stream of oil company spending cuts means for crude prices pall the companies in jeff bezos’s empire in one large chart pbitcoin investors things may get very ugly soon if this chart overlay is right pbaidu adrs rally  after earnings beat pbreakingsenators demand house conference promise before voting on skinny obamacare repeal pjonathan golub leaves rbc to head equities strategy at credit suisse report pamazon earnings forecast shows spending expected to continue pa quarter of sp ’s  climb due to five stocks yes those five pnuvasive shares drop after announced coo cfo departures pboston beer jumps on stellar secondquarter earnings loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cara stock price  cara therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern p redfin prices ipo higher than expected for  billion valuation p spacex valuation jumps to  billion on new financing round p headline sen graham the skinny bill is a disaster p updated howard marks says bitcoin isn’t real—and we can all blame millennials for its rise p senate passes russia sanctions bill on  vote p updated scaramucci provides a shocking bannon comparison that defies anatomy p updated ethereum struggles to rise as regulatory scrutiny weighs on digital currency p this fund strategist says there’s at least one way companies can survive amazon’s onslaught p this basic balanced index fund is beating the hedge fund averages p tesla earnings will model  live up to the hype to be replaced home investing quotes stocks united states cara overview compare quotes stock screener earnings calendar sectors nasdaq cara us nasdaq join td ameritrade find a broker cara therapeutics inc watchlist createcaraalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones update cara therapeutics shares surge  premarket on positive trial results shares of cara therapeutics inc surged  in premarket trade wednesday after the company reported positive results in an earlystage trial of a treatment for chronic kidney diseaseassociated pruritus patients or ckdap pruritus or itch is a common symptom for patients with chronic renal failure affecting about half of those with stage  to  ckd cara said results from the phase  trial of oral cr in chronic kidney disease patients undergoing hemodialysis showed all four tablet strengths were welltolerated on a daily basis or after dialysis three times a week cr is a peripherally acting kappa opioid receptor agonist currently in development for the treatment of acute and chronic pain and pruritus said cara plasma levels of cr attained after oral administration of the  mg tablet strength were close to those attained with the  mcgkg iv cr dose which demonstrated significant clinical benefit in another recent trial the company said frédérique menzaghi phd vice president of research and development at cara said the data will inform the design of a planned oral cr pruritus clinical program in the nondialysis ckdap population which the company is planning to start later this year cara shares have gained  in  while the sp  has gained  jul   at  am et by ciara linnane cara therapeutics shares jump  in premarket trade cara therapeutics shares jump  in premarket trade jul   at  am et by ciara linnane cara therapeutics reports positive results in earlystage trial of pain treatment in kidney disease cara therapeutics reports positive results in earlystage trial of pain treatment in kidney disease jul   at  am et by ciara linnane nasdaq sp  close higher as tech stocks rally while dow dips jul   at  pm et by sara sjolin cara therapeutics stock declines  in morning trade cara therapeutics stock declines  in morning trade jul   at  am et by emma court cara therapeutics stock plunges after mixed trial results prompts analyst downgrade shares of cara therapeutics inc plunged  in premarket trade friday after mixed results from a phase b trial of the biotechnology companys pain medication prompted a downgrade at janney montgomery scott analyst ken trbovich cut his rating to neutral from buy saying the results of the trial werent strong enough to achieve statistical significance at the highest dose and did not show an effect at lower doses the result of the trial gives us less confidence in the outlook for a positive outcome for the phase  than we had previously trbovich wrote in a note to clients the stock had nearly tripled year to date through thursday while the ishares nasdaq biotechnology etf had rallied  and the sp  had gained  jun   at  am et by tomi kilgore opinion harry boxer’s two biotech stocks and two tech stocks to watch jun   at  pm et by harry boxer opinion harry boxer four stocks locked in a strong uptrend may   at  pm et by harry boxer sp  balks at trendline resistance nasdaq stages latest false breakout apr   at  pm et by michael ashbaugh opinion harry boxer’s five technology and biotechnology stocks to watch mar   at  pm et by harry boxer cara therapeutics shares surge  on positive results in trial of up treatment mar   at  am et by ciara linnane opinion harry boxer watch these two biotechnology stocks feb   at  am et by harry boxer cara therapeutics shares are up more than  premarket nov   at  am et by marketwatch stocks to watch nvidia nrg energy american airlines twitter among the companies with shares expected to trade actively in monday’s session are nvidia corp nrg energy inc american airlines group inc and twitter inc jul   at  am et on the wall street journal bear case backs down mar   at  am et on the wall street journal  small healthcare stocks poised to double dec   at  am et on barrons holy grail pain pills without the high mar   at  pm et on the wall street journal up and down the ladder the latest comings and goings at astellas johnson  johnson and… dec   at  am et on the wall street journal recent news other news press releases these  marijuana stocks all jumped at least  last week jul   at  am et on motley fool top marijuana stocks on the nasdaq most marijuana companies trade otc but these names are listed on the nasdaq and enjoy greater liquidity jul   at  am et on investopediacom  reason why cara therapeutics ended june down  jul   at  pm et on motley fool why this biotech could be poised for a run after toppling  in june cara therapeutics cara stock popped wednesday after the biotech unveiled strong data from a phase  trial of chronic kidney disease patients — giving its shares a leg up for the second day running cara shares have been volatile over the past month cara was the de facto leader of a latejune spike in the biotech market the stock rocketed  in just six trading days but lost it all on the last day of the month amid a mixed trial in hip and jul   at  pm et on investors business daily heres why cara therapeutics inc is on the rise today jul   at  pm et on motley fool caras oral cr welltolerated in earlystage study shares ahead  premarket caras oral cr welltolerated in earlystage study shares ahead  premarket jul   at  am et on seeking alpha  stocks to watch on wednesday square inc sq cara therapeutics inc cara and healthcare services group inc hcsg  stocks to watch on wednesday square inc sq cara therapeutics inc cara and healthcare services group inc hcsg jul   at  am et on investorplacecom this marijuana stock has lost more than half its value in  weeks jul   at  am et on motley fool can cara therapeutics stock bounce back jul   at  pm et on motley fool raytheon has a lot of upside  cramers lightning round  raytheon has a lot of upside  cramers lightning round  jul   at  am et on seeking alpha brunch craft beer and investing a millennials portfolio brunch craft beer and investing a millennials portfolio jul   at  pm et on seeking alpha why best buy co inc bby abercrombie  fitch co anf and cara therapeutics inc cara are  of today’s worst stocks why best buy co inc bby abercrombie  fitch co anf and cara therapeutics inc cara are  of today’s worst stocks jul   at  pm et on investorplacecom heres why nobodys itching to buy cara therapeutics stock today jul   at  pm et on motley fool biotech forum daily digest  ipo activity increasing spotlight on flexion therapeutics biotech forum daily digest  ipo activity increasing spotlight on flexion therapeutics jul   at  pm et on seeking alpha cara option alert feb   puts sweep  at the ask    vs  oi ref cara option alert feb   puts sweep  at the ask    vs  oi ref jul   at  pm et on benzingacom phase b cara therapeutics data provides great short opportunity phase b cara therapeutics data provides great short opportunity jul   at  am et on seeking alpha daily insider ratings round up  mcc cnbka opk cara kfs mmac daily insider ratings round up  mcc cnbka opk cara kfs mmac jul   at  am et on seeking alpha up in smoke heres why this marijuana stock absolutely imploded last week jul   at  am et on motley fool biotech stock roundup cara plunges on study data regulatory updates  more key highlights in the biotech sector include mixed data from cara cara and regulatory updates from companies like biomarin jul   at  am et on zackscom biotech forum daily digest  biotech fritters away some gains  fda calendar events in july biotech forum daily digest  biotech fritters away some gains  fda calendar events in july jul   at  am et on seeking alpha cara therapeutics to announce second quarter  financial results on august   cara therapeutics to announce second quarter  financial results on august   jul   at  pm et on globenewswire potential blockbuster treatment for alzheimers disease stands out among medical cannabis companies potential blockbuster treatment for alzheimers disease stands out among medical cannabis companies jul   at  am et on pr newswire  prf the next gold rush is green the next gold rush is green jul   at  am et on pr newswire  prf sales of legal cannabis products are expected to accelerate sales of legal cannabis products are expected to accelerate jul   at  am et on pr newswire  prf cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease jul   at  am et on globenewswire correction todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals inc correction todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals inc jul   at  am et on accesswire investors covered call reports for cara therapeutics national beverage corp kraft heinz co mcdonalds and att include trade ideas that offer returns of  or more investors covered call reports for cara therapeutics national beverage corp kraft heinz co mcdonalds and att include trade ideas that offer returns of  or more jul   at  am et on pr newswire  prf todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals todays research reports on stocks to watch cara therapeutics and threshold pharmaceuticals jul   at  am et on accesswire cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee jun   at  pm et on globenewswire legal cannabis and cbdbased products projected to gain popularity legal cannabis and cbdbased products projected to gain popularity jun   at  am et on pr newswire  prf todays research reports on trending tickers aveo pharmaceuticals and cara therapeutics todays research reports on trending tickers aveo pharmaceuticals and cara therapeutics jun   at  am et on accesswire todays stock options reports include trade ideas for cara therapeutics chemours co dunkin brands trade desk inc and united parcel service todays stock options reports include trade ideas for cara therapeutics chemours co dunkin brands trade desk inc and united parcel service jun   at  am et on pr newswire  prf biotech stocks showing signs of resurgence biotech stocks showing signs of resurgence jun   at  am et on pr newswire  prf cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients jun   at  am et on globenewswire todays research reports on stocks to watch hologic and cara therapeutics todays research reports on stocks to watch hologic and cara therapeutics jun   at  am et on accesswire cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment jun   at  am et on globenewswire consumers spending on legal cannabis products projected to grow consumers spending on legal cannabis products projected to grow jun   at  am et on pr newswire  prf research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma research reports coverage on biotech stocks  anthera pharma cara therapeutics cerus and concert pharma jun   at  am et on pr newswire  prf cbd market becomes major part of the cannabis industry cbd market becomes major part of the cannabis industry may   at  am et on pr newswire  prf cannabisbased therapies with potential to dull the pain of opioid abuse cannabisbased therapies with potential to dull the pain of opioid abuse may   at  am et on pr newswire  prf cara therapeutics inc cara therapeutics inc is a clinicalstage company which engages in the research development and commercialization of pharmaceutical products its portfolio includes opioidbased products anestheticbased drugs and analgesics that targets to alleviate itch and pain the company was founded by derek t chalmers michael e lewis and frédérique menzaghi on july   and is headquartered in stamford ct see full profile analyst ratings sell under hold over buy number of ratings  full ratings cara therapeutics topline data disappoints this is why you do phase  jun   at  am et on benzingacom benzingas top upgrades downgrades for june   jun   at  am et on benzingacom cara therapeutics ends mixed month with upgrade from vetr crowd mar   at  pm et on benzingacom competitors name chg  market cap depomed inc  m durect corp  m acorda therapeutics inc  b cumberland pharmaceuticals inc  m johnson  johnson  b competitor data provided by partner content trending tickers powered by amzn  intc  sbux  fslr  bidu  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft cara therapeutics inc cara  stock predictions  price targets facebook autocomplete demo post a rating  month price target   home trending sign up log in cara therapeutics inc cara  last  days median target price   upside positive ratings  of  analysts latest  canaccord genuity  positive   view all analyst ratings for cara » facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising pharmaceutical product development for pruritus  pain  cara therapeutics careers  working to fundamentally change the way pain and pruritus are managed developing proprietary firstinclass compounds to treat pain inflammation and pruritus without inducing many of the side effects associated with current therapies learn more acute pain acute pain is of sudden onset and is usually the result of a clearly defined cause such as injury chronic pain chronic pain persists for two weeks or months and is usually associated with an underlying condition pruritus pruritus or itch is defined as an unpleasant sensation of the skin that provokes the urge to scratch press releases cara therapeutics to announce second quarter  financial results on august    cara therapeutics announces summary data from phase  trial of oral cr in hemodialysis patients with chronic kidney disease  cara therapeutics announces topline results from phase b trial of oral cr in chronic pain patients with osteoarthritis of the hip or knee  cara receives breakthrough therapy designation from fda for iv cr for the treatment of chronic kidney diseaseassociated pruritus in hemodialysis patients  cara therapeutics reports continuation of phase  trial of iv cr in postoperative pain following interim assessment  events  presentations q  cara therapeutics earnings conference call  cr oa phase b data conference call  ckdassociated pruritus kol meeting  q  cara therapeutics earnings conference call  cara ceo interviewed on cnbcs mad money  bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one